Livzon Pharmaceutical Group (1513.HK) Q2 2025 Earnings

23AprConfirmed
Q2 2024
Q3 2024
Q4 2024
Q2 2025
0.59
0.65
0.7
0.76

Details

Expected EPS
0.7482351744
Actual EPS
0.7589242483199999
Surprise EPS
0.01
Surprise Percent
+1.43%

Description

Livzon Pharmaceutical Group (1513.HK) has reported earnings of 0.7589242483199999 per share for Q2 2025.

0 Comments

Share your thoughts